Japan Pharmas Seeing Lowest Stock Prices In Industry History
This article was originally published in PharmAsia News
Executive Summary
Japanese pharmaceutical companies are experiencing some of the lowest stock values in the history of the industry, led by Takeda Pharmaceutical and Astellas Pharma in share-price plunges. The Japan drop is sharing the fate of U.S. and European competitors as drug makers face government cutbacks in medical expenses and patents expire for some key products. Pharmas in developed countries are beginning to focus their attention more on emerging markets where incomes are increasing, but Japanese pharmas trail in that switch. (Click here for more - a subscription may be required